Last reviewed · How we verify
NCT05251454
Studying the Effects of Brain Stimulation on Cognitive Control and Associated EEG in Human Subjects.
NA trial testing Brain Stimulation in Cognitive Deficit in 5 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2025
Quick facts
| Lead sponsor | University of Cincinnati |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 5 |
| Start date | 20 June 2022 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Brain Stimulation
Conditions studied
- Cognitive Deficit — all drugs for Cognitive Deficit →
Sponsor
University of Cincinnati
Who can join
Adults 18 to 70, any sex, with Cognitive Deficit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a basic neuroscience study of modulating brain oscillations involved in cognitive control. We will record brain signals and stimulate specific regions of the brain in human participants who are undergoing monitoring for epilepsy surgery. It is not a clinical trial for treating any disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05251454
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Brain Stimulation
Trials testing the same drug.
- NCT06642519 — Brain-Machine Interface for Freezing of Gait · NA · enrolling by invitation
- NCT05529264 — Human Intracranial Electrophysiology · NA · recruiting
Other recruiting trials for Cognitive Deficit
Currently open trials in the same condition.
- NCT06278532 — Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS · recruiting
- NCT06820125 — Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation · NA · recruiting
- NCT05802680 — Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation · NA · recruiting
- NCT04822987 — Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs) · active not recruiting
Other University of Cincinnati trials
Trials by the same sponsor.
- NCT05605366 — Minocycline In Neurocognitive Outcomes - Sickle Cell Disease · Phase 1 · not yet recruiting
- NCT07528638 — Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND) · NA · not yet recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07447895 — Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies · NA · not yet recruiting
- NCT07231588 — Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05251454 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cincinnati
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05251454.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing